Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab

BACKGROUND: Due to the complex molecular structure and proprietary manufacturing processes of monoclonal antibodies (mAbs), differences in structure and function may be expected during development of biosimilar mAbs. Important regulatory requirements for approval of biosimilar products involve compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Velayudhan, Jyoti, Chen, Yuh-feng, Rohrbach, Amanda, Pastula, Christina, Maher, Gwen, Thomas, Heather, Brown, Ryan, Born, Teresa L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972870/
https://www.ncbi.nlm.nih.gov/pubmed/27422671
http://dx.doi.org/10.1007/s40259-016-0185-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4972870/
https://www.ncbi.nlm.nih.gov/pubmed/27422671
http://dx.doi.org/10.1007/s40259-016-0185-2

Ejemplares similares